Did you know pharmaceutical companies lose $4.5-9.0 billion every year because of manufacturing rejects? This lean six sigma case study reveals something surprising: semiconductor companies maintain an excellent 6σ defect rate, while pharma companies struggle with reject rates between 5% and 10%.
Our work with pharmaceutical companies has shown how pharmaceutical lean six sigma manufacturing applications can revolutionize operations. Manufacturing costs make up 36% of a pharmaceutical manufacturer’s expenses which is more than double the R&D costs. A pharma project that wanted to cut changeover time by just 20% ended up achieving a remarkable 43% improvement. This improvement matters even more now because operational excellence has become both a business necessity and a regulatory expectation in the pharmaceutical industry.
In this article, we’ll get into how a pharmaceutical giant saved $12 million and improved quality at the same time. I am hoping that lessons from this lean six sigma case study could help and change your organization as well.
The challenge: Why change was needed at the pharma giant
The pharmaceutical giant faced a harsh truth: the industry wastes over $50 billion each year due to poor manufacturing practices [1]. While semiconductor companies excel at quality control, pharma companies lag behind at 2-3 sigma levels and produce 25-35% defective products [2]. This gap shows just how much room exists to improve!
Several critical problems created these troubling numbers. Quality issues ran rampant throughout operations – from raw materials that weren’t consistent to manufacturing that varied too much. Research has shown that manufacturing and product quality problems caused 60% of drug shortages between 2013 and 2017 [3].
Regulatory compliance created constant problems in operations worldwide. Different countries have different rules and enforce their own rules, which makes standardization difficult [4]. The company recognized that this complexity not only hindered efficiency but also increased the risk of non-compliance with regulatory standards. To address these issues, they initiated a comprehensive review of their processes, aiming to streamline operations and enhance product quality. By focusing on simplification, they hoped to reduce variability and ultimately improve their sigma levels, aligning more closely with industry best practices.
Supply chain weaknesses created yet another major challenge. Operations became vulnerable to geopolitical risks [6] because they depended heavily on imported ingredients. The recent pandemic made this weakness crystal clear.
The pressure to control costs kept growing as well. Raw materials, labor, and logistics expenses cut deeper into profit margins [6]. The company saw that traditional batch production had many more risks than continuous manufacturing [3].
These challenges meant the company needed to completely rethink its operations. This created the perfect chance to let lean six sigma methodology shine.
The Lean Six Sigma approach: Step-by-step breakdown
The team tackled their challenges by implementing DMAIC methodology. This evidence-based problem-solving approach provided a clear roadmap through five phases: Define, Measure, Analyze, Improve, and Control.
The Define phase brought stakeholders together to create a project charter. The team outlined their objectives, scope, and timeline. They crafted a problem statement and analyzed stakeholder needs to capture everyone’s input. An most important of all the team captured the Voice of Customer to understand the needs, wants and expectations of the Project Sponsor.
The Measure phase revealed the baseline performance data, highlighting inefficiencies that had previously gone unnoticed. Quality indicators emerged from careful analysis, allowing the team to pinpoint specific areas for improvement. Utilizing process maps and Pareto charts, they gained a clear visual representation of their current standing, setting the stage for targeted interventions[7].
The Analyze phase uncovered why things happened through fishbone diagrams and “5 Whys” techniques. By systematically dissecting each issue, the team was able to identify root causes that had previously eluded them. This deep dive into the data not only clarified the problems but also fostered a culture of continuous improvement, empowering team members to take ownership of their roles in the process[7].
In the Improve phase, the team turned insights into action. Team members brainstormed ideas and piloted solutions on a small scale. They watched the results carefully and eliminated any problems they identified [7].
In the Control phase, the team created robust monitoring systems. Team’s detailed control plan assigned clear ownership of each process component. This approach secured the $12M in savings [8].
Yes, it is remarkable how this methodical approach revolutionized operational excellence. What started as a business target quickly became a regulatory standard in the pharmaceutical industry.
Results and impact: How $12M was saved
The numbers tell an amazing story! This pharmaceutical giant didn’t just meet their ambitious goals. They shattered them and proved that lean manufacturing extends beyond Toyota’s success.
Their achievements speak for themselves: they saved $12 million through systematic improvements. The team cut product changeover times in half, from 12 hours to 6 hours. The lot-to-lot changeovers saw even better results, dropping from 4.5 hours to just 1.5 hours [9].
These improvements boosted their production capacity by 28% [10]. The impact was substantial. They produced between 200,000 and 750,000 more units each month while maintaining their quality standards [9].
The team found hidden opportunities to improve efficiency throughout their operations. Their Advanced Planning and Scheduling system’s data revealed that the cleaning crew didn’t need 24-hour coverage. Moving them to day shifts created substantial cost savings [10].
The company achieved these impressive results while adhering to strict FDA compliance standards [9]. This showcases a fundamental change in the pharmaceutical industry where operational excellence has evolved from a business target to a regulatory requirement.
The organization now makes more products efficiently with fewer resources. Their lead times are shorter and quality is higher, exactly what a well-executed Six Sigma program delivers.
Conclusion
This eye-opening case study proves Lean Six Sigma isn’t just another manufacturing buzzword. It’s a game-changer for pharmaceutical companies trying to cut costs from their operations. The company saved $12 million through systematic problem-solving with the DMAIC framework.
The results are impressive. They cut changeover times in half and increased production capacity by 28% without compromising quality. It’s like finding money in your couch cushions, except we’re talking millions, not quarters! The pharmaceutical giant produced 750,000 more units monthly while maintaining FDA compliance.
The pharmaceutical industry’s evolution makes this story relevant today. Regulators now expect operational excellence, not just see it as a business goal. Quality compliance and efficiency initiatives work together – they’re two sides of the same pill.
The most valuable lesson shows how improvements often hide in plain sight. A simple change in the cleaning crew’s schedule contributed by a lot to those millions saved. Small changes added up to create big results.
The pharmaceutical industry hasn’t caught up with sectors like semiconductors in efficiency yet. This case study shows huge room for improvement. The industry could save $90 billion worldwide – that’s something to think about!
Our ground experience shows how Lean Six Sigma principles can change pharmaceutical operations when used correctly. Companies that accept new ideas will see benefits beyond financial gains. They’ll see improved quality, less waste, and optimized processes. A healthy dose of Lean Six Sigma might be the prescription for success in pharmaceutical manufacturing.
Key Takeaways
This pharmaceutical case study demonstrates how systematic process improvement can deliver massive financial returns while enhancing quality and compliance.
• DMAIC methodology delivered $12M savings by reducing changeover times 50% and boosting production capacity 28% without additional resources
• Pharmaceutical manufacturing wastes $50+ billion annually with 25-35% defect rates, creating massive improvement opportunities through Lean Six Sigma
• Small changes create big impact – simple adjustments like rescheduling cleaning crews contributed significantly to overall cost savings
• Operational excellence is now regulatory expectation – FDA compliance and efficiency improvements must work together, not separately
• Hidden opportunities exist everywhere – analyzing existing data systems revealed unexpected efficiency gains worth hundreds of thousands monthly
The pharmaceutical industry’s potential for $90 billion in worldwide efficiency savings makes Lean Six Sigma not just beneficial, but essential for competitive survival and regulatory compliance.
References
[1] – https://source.washu.edu/2006/10/pharmaceutical-industry-wastes-50-billion-a-year-due-to-inefficient-manufacturing/
[2] – https://pmc.ncbi.nlm.nih.gov/articles/PMC4605917/
[3] – https://news.ashp.org/news/ashp-news/2023/05/10/improving-quality-of-drug-manufacturing-is-critical-to-stemming-shortages
[4] – https://www.americanpharmaceuticalreview.com/Featured-Articles/616753-Navigating-Global-Expansion-Optimizing-Local-QPPVs-And-Regulatory-Lifecycle-Management-for-Mid-Size-Pharma/
[5] – https://www.ncbi.nlm.nih.gov/books/NBK570315/
[6] – https://www.consultdss.com/content-hub/operational-excellence-key-to-sustainable-growth-in-pharma-industry/
[7] – https://pmc.ncbi.nlm.nih.gov/articles/PMC10229001/
[8] – https://www.sixsigmaonline.org/dmaic-control-phase/
[9] – https://tbmcg.com/resources/blog/4-ways-free-up-significant-capacity-pharmaceutical-processing/
[10] – https://www.theaccessgroup.com/en-gb/manufacturing/industries/pharmaceutical/scaling-up-in-pharma-and-biopharma/
Leave a Reply